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Abstract
Background Matrix metalloproteinase-9
(MMP-9) secreted by corneal epithelial cells
has a role in the remodelling of extracellular
matrix and migration of epithelial cells.
Elevated levels of MMP-9 activity in
the ocular surface may be involved in
the pathogenesis of corneal diseases.
N-acetylcysteine (NAC) has been used to
treat corneal diseases, including recurrent
epithelial erosions. In this study, its effects
on the MMP-9 secretion and human corneal
epithelial (HCE) cell migration were
evaluated in vitro.
Methods Confluent HCE cell cultures were
treated with 0–20mM NAC, and tested for
MMP-9 secretion and epithelial cell
migration by gelatin zymography and scratch
wound assay, respectively. Comparisons
between different treatment groups were
made using analysis of variance, followed
by multiple pairwise comparisons.
Results TwentymM NAC inhibited the
secretion of MMP-9 significantly. Cell
migration, assessed after 24h of wounding,
showed a highly significant dose-dependent
inhibitory effect.
Conclusions This study shows that
NAC reduces MMP-9 production by HCE
cells and inhibits cell migration in vitro.
This information helps to elucidate
the mechanisms by which NAC may be
beneficial therapeutically and suggests
that NAC may be useful for managing
corneal erosions and related conditions.
Eye (2012) 26, 1138–1144; doi:10.1038/eye.2012.135;
published online 6 July 2012
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Introduction
Corneal injuries elicit inflammatory responses
that eliminate the injurious agent and facilitate
healing. Corneal inflammation occurs in various
conditions and irrespective of the underlying
cause, this often results in tissue destruction
that leads to corneal ulceration, scarring,
and even perforation. Pathological activity of
proteolytic enzymes and active pro-
inflammatory cytokines are implicated in the
progression of tissue destruction.1–3 The early
phases of healing that follow inflammation
are characterised by deposition of extracellular
matrix (ECM), and proliferation and
migration of cells within this matrix, which
acts as a scaffold. This is followed by a
remodelling phase, in which the ECM is
degraded by proteolytic enzymes.1 Matrix
metalloproteinases (MMPs) are a group of
proteases that have a role in ECM remodelling
and the tissue inhibitors of metalloproteinases
(TIMPs) interact with MMPs to modify their
biological roles in tissues.1,4,5
MMPs are secreted by corneal epithelial cells
and stromal keratocytes and have a role in the
remodelling of ECM and migration of corneal
epithelial cells on the underlying stroma. TIMPs
are also secreted by corneal epithelial cells.5
The activity of MMP-9 is upregulated in ocular
surface diseases, such as recurrent corneal
erosion (RCE),3 peripheral ulcerative keratitis,2
ocular rosacea,6 and dry eye.4 Elevated MMP-9
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activity in these conditions may be involved in the
pathogenesis of the disease. MMPs participate at
all stages of the ulcerative process, from initiating the
epithelial defect to ulcer resolution and repair.1 Although
collagenolytic and gelatinolytic processes are essential
for tissue remodelling and wound healing, down-
regulation of their activity is essential to maintain
tissue stability after initial wound healing.1 Therefore,
prevention of ECM degradation through inhibition of
MMP activity may be an effective therapeutic approach
to treat corneal ulcers.
N-acetylcysteine (NAC), a mucolytic agent, has been
used in ophthalmology to treat corneal diseases,
including alkali-burned corneal ulcers,7 and filamentous
keratitis.8 Although the effects of NAC on the corneal
surface and wound healing have been described in
several studies,9–13 the effects of NAC on the secretion of
MMPs in human corneal epithelial (HCE) cells have not
been investigated to date. We hypothesised that NAC
modulates the MMP-9 secretion in the HCE cells and
TIMPs may be involved in the regulation of MMP-9. The
purpose of this study was to evaluate the effect of NAC
on the secretion of MMP-9 and TIMPs and on corneal
epithelial cell migration using cultured HCE cells.
Materials and methods
HCE cell cultures
Corneoscleral rims from the donor corneoscleral buttons
remaining after corneal transplantation were used to
culture HCE cells. These corneoscleral buttons were
obtained from the Manchester Eye Bank. Ethical
approval was obtained from Lothian NHS (Edinburgh)
Research Ethics Committee. The HCE cells were
isolated using 0.125% trypsin/EDTA and seeded onto
mitomycin-C inactivated 3T3 fibroblasts (2.4 104 cells/
cm2) in 12-well plates and incubated with culture media
(Dulbecco’s modified Eagle’s medium and Ham’s F12
mixture, supplemented with 10% FCS, 4 10 3 mol/l
glutamine, 1.8 10 4 mol/l adenine, 5mg/ml insulin,
2 10 7 mol/l triiodo-L-thyronine, 0.4 mg/ml
hydrocortisone, 10 ng/ml epidermal growth factor,
100 IU/ml penicillin-streptomycin ,and 0.5 mg/ml
amphotericin B) at 371C under 5% CO2. When the
epithelial cells were confluent (almost all the 3T3 cells
were removed), they were used for MMP-9, TIMPs,
and migration assays.
For MMP assay, the cells were washed with PBS and
incubated with equal volumes of serum-free media
containing NAC (Sigma, Poole, UK) at 0, 0.1, 1.0, 5.0, 10,
and 20 mM. After 24 h, media were separated and stored
at  201C until the MMP assay. Four sets of experiments
were conducted with four different donor samples. The
viability of cells in each well after treatment was assessed
in two sets of experiments by Trypan blue exclusion after
trypsin digestion to exclude cytotoxicity. In addition, in
two sets of experiments, cells were left with NAC for
further 24 h to investigate the effect of longer exposure
to NAC (48 h).
Gelatin zymography and reverse zymography
A volume of 3 ml of conditioned media from each sample
was diluted 1 : 1 with deionised water, mixed with 6ml
of sample application buffer, and subjected to gelatin
zymography as described by Ramaesh et al.14 For
quantitative analysis, the gelatin zymograms were
produced by loading further diluted conditioned media,
containing only 1 ml of each sample. This was done to
produce a clear non-overlapping band for each sample.
The bands of gelatinolytic activity detected by
zymography were analysed quantitatively by a GS-700
Imaging Densitometer (Bio-Rad, Hemel Hempstead, UK)
and the density of the bands were expressed as
uncalibrated optical density (uOD).14
The secretion of TIMPs was detected by reverse
zymography as described in Riley et al.15 Briefly, samples
of 7.5 ml conditioned media were separated according to
molecular weight by PAGE (12% gels) containing gelatin
(1 mg/ml) and a preparation of MMP-2 (conditioned
medium from baby hamster kidney cells, BHK-21, which
constitutively express MMP-2). Gels were washed,
incubated in reverse zymography digestion buffer, and
then stained with Coomassie blue. The inhibitory activity
of TIMP with substrate degradation by MMP-2 appeared
as dark bands against a lighter background.
Epithelial cell migration assay
HCE cells were grown to confluence in 12-well plates,
and a 1-mm wide linear wound was made with a cell
scraper. After being rinsed twice with PBS, the cells were
allowed to migrate in serum-free media containing NAC
at 0, 0.1, 1.0, 5.0, 10, and 20 mM at 371C under 5% CO2 for
24 h. The wound width was measured at three different
points for the linear wound in each well at 0, 6, and 24 h,
and the migration distance was calculated for 6 and 24 h.
Immunostaining
Confluent HCE cells were fixed in 4% paraformaldehyde
in PBS at 41C for 10 min, washed in PBS, and then treated
with 0.5% TritonX-100 in PBS at room temperature for
10 min. Cells were treated with normal serum (1% goat
serum, 1% bovine serum albumin) for 30 min and
incubated with primary antibodies, rabbit anti-human
polyclonal cytokeratin 12 antibody (1 : 50, Santa Cruz,
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Wembley, UK), and rabbit anti-mouse polyclonal
cytokeratin 19 (type 1) antibody (1 : 100, LifeSpan
Biosciences, Newmarket, UK) at 41C for overnight. The
cells were incubated at room temperature for 1 h with
goat anti-rabbit Alexa Fluor 488 (1 : 400, Invitrogen,
Paisley, UK) finally counterstained with TOPRO-3 and
mounted. Cells were washed with 0.2% TritonX-100 in
PBS after incubation with antibodies. Control samples
were incubated with normal serum, but otherwise
treated in the same way. Samples were visualised by
fluorescence microscopy.
Statistical analysis
MMP-9 secretion and cell migration of corneal epithelial
cells were analysed by a single factor analysis of variance
(ANOVA) for the optical densities and the migration
distance, respectively, for different groups. Comparisons
between different treatment groups were made using
ANOVA, followed by multiple pairwise comparisons
with Bonferroni/Dunn’s post hoc tests and the results
were considered statistically significant where Po0.0033,
to allow for multiple tests.
Results
HCE cell cultures
HCE cells cocultured with 3T3 cells became confluent
around 14 days and by this time very few 3T3 cells
remained in the cultures. The epithelial cell population
consisted of colonies of large cells that were positive for
K12 (Figure 1a) and small cells that were K19-positive
(Figure 1b). The viability of cells, as assessed by Trypan
blue after trypsin digestion to detach epithelial cells into
cell suspension, was 87–95%.
Secreted MMP activity and TIMPs
The conditioned media obtained from the cultures
exhibited bands at 92 kDa corresponding to MMP-9
activity, when 3 ml of samples were loaded (Figure 2a).
The zymograms showed a dose-dependent reduction of
secreted MMP reflected in the activity assay for cells
grown in different NAC concentrations. Gelatin
zymograms produced with 1 ml volume samples showed
non-overlapping bands (Figure 2b) and these zymograms
were used for quantitative assays. Conditioned media
obtained from the wells that contained only 3T3 cells did
not produce MMP-9 bands (Figure 2b). A dose-related
effect of NAC on MMP-9 activity is illustrated by the
histogram (Figure 2c), which shows the mean optical
density (uOD) values for the bands of MMP-9 activity.
ANOVA showed a significant difference (Po0.0005)
among treatments with different concentrations of NAC
for MMP-9 activity (optical density of bands in the
zymogram). Pairwise comparisons showed significant
differences between 20 mM NAC and lower
concentrations (Figure 2c).
Reverse zymograms of conditioned media showed
bands at 28 kDa corresponding to TIMP-1 for some
samples (Figure 3), although the results were not
consistent.
HCE cell migration
Reduction in wound size was observed in all treatment
groups after 6 h. Representative images of some of the
Figure 1 Immunocytochemistry images of cytokeratin 12 and 19 (K12 and K19) localisation in cultured HCE cells. (a) K12
immunostaining of differentiated HCE cells (green); (b) K19 immunostaining of undifferentiated cells (green); (c, d) negative controls
for K12 and K19, respectively. Nuclei are stained blue with DAPI. Scale bar¼ 100mm.
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treatment groups are shown in Figure 4a. Average cell
migration distance was calculated for each linear wound
after 6 and 24 h, and the mean values are shown in
Figure 4b. There was no significant difference between
groups for cell migration distance after 6 h. However,
after 24 h a dose-dependent reduction in cell migration
was observed with the wounds completely closed in
most of the wells treated with 0, 0.1, 1.0, 5.0, and 10 mM
NAC and only partially closed in most of the wells
treated with 20 mM NAC. There was a significant
difference (Po0.0001) among treatments for cell
migration distance after 24 h by ANOVA. Pairwise
comparisons showed significant differences between
higher and lower concentrations (Figure 4).
Although after 24 h there was no difference in the cell
morphology and viability of cells treated with different
concentration of NAC, cell morphology was affected
after 48 h in cultures treated with higher concentrations
of NAC (5, 10, and 20 mM, Figure 5). The epithelial cells
tended to detach from the surface and the nuclei were
fragmented in some cells implying cytotoxicity in
cultures with continuous treatment of NAC.
Discussion
These results are the first to demonstrate that that NAC is
effective at reducing MMP-9 secretion in HCE cell
cultures in a concentration-dependent manner
(significant for 20 mM and a non-significant trend for
10 mM). Although TIMPs were produced by HCE cells in
cultures treated with NAC, they were not detected in all
samples. This study also shows that NAC decreased the
rate of HCE cell migration in vitro (significant for both 10
and 20 mM).
NAC is a derivative of cysteine, which inhibits
collagenase irreversibly by reducing disulphide bonds
and by chelating calcium or zinc. It also inhibits MMP-9,
potentially by similar mechanisms, although it is less
potent and therefore requires a higher concentration.16
NAC also inhibits MMP-9 produced by bladder cancer
cells17 and fetal membranes.18 Further, NAC has been
shown to inhibit inflammatory cytokine responses in
amniotic fluid and placental tissue in rats.19 The present
finding of inhibitory effect of NAC on MMP-9 secretion
and the reports on the inflammatory responses suggest
Figure 2 Effects of NAC on MMP-9 secretion. (a, b) Gelatin
zymography of conditioned media from cultured HCE cells
treated with different concentrations of NAC. (a) Conditioned
media exhibited strong bands at 92 kDa, corresponding to
MMP-9 activity. (b) The same sample as in (a), loaded at a
lower volume (1ml). In the first two lanes, conditioned media of
3T3 cells was loaded at (a) 1ml and (b) 7.5ml, and they did not
exhibit bands for MMP-9. C, control sample, human amniotic
fluid, which contains MMP-9. Right: protein markers and the
corresponding molecular weights. (c) Histogram showing the
MMP-9 activity assay, expressed as optical densities of the bands
(uOD). Each bar represents the mean±SEM of four samples.
Pairwise comparisons showed significant differences between 0
vs 20 mM (P¼ 0.0001), 0.1 vs 20 mM (Po0.0001), 1.0 vs 20 mM
(Po0.0001), and 5 vs 20 mM (P¼ 0.0005) NAC treatment groups.
Figure 3 Effects of NAC on TIMPs secretion. Reverse
zymography of conditioned media from cultured human corneal
epithelial cells treated with different concentrations of NAC-
acetylcysteine for two samples. Bands at 28 kDa, corresponding
to TIMP-1, were detected for some of the NAC treatments, but
the results were not consistent for all samples (eg, sample 2).
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that NAC may be useful clinically to treat destructive
corneal conditions in which MMP-9 activity and
inflammatory cytokines are upregulated.
Although the exact mechanism of inhibition of
MMP-9 secretion by NAC is currently unknown, the
inhibitory properties of NAC on inflammation has been
shown to act through nuclear factor-kB (NF-kB), which
has a pivotal role in inducing the expression of
multiple genes in immune and inflammatory
responses.18,20 Inactive NF-kB is cytoplasmic and
in response to activation by oxidative stress and action
of reactive oxygen species it undergoes phosphorylation
and translocates to the nucleus to initiate transcription
by high affinity binding to regulatory kB motifs.21 These
kB motifs have been identified in the promoter region of
a number of genes involved in the phospholipid
metabolic pathway, pro-inflammatory cytokines, MMP-9,
and urokinase-type plasminogen activator.21 NAC has
been shown to inhibit upstream events that lead to
NF-kB activation. As well as inhibiting MMP-9 via its
action on NF-kB, NAC may also have a direct inhibitory
effect on MMP-9 by reducing disulphide bonds,
as noted above.
In our in vitro system, the corneal epithelial wound
healing was inhibited in the presence of 10 and 20 mM
NAC after 24 h, although there was no difference in
healing after 6 h. Further, we have found that continuous
treatment of NAC for 48 h showed toxic effects on HCE
cells. In most in vitro studies, NAC is measured in terms
of molar concentration (molarity), whereas clinical
studies usually quote a percentage concentration. Our
maximum dose of 20 mM NAC is equivalent to a 0.33%
solution, which is much lower than the solutions
used clinically. Although, in clinical studies, topical
applications of 5 and 20% NAC have been shown to be
effective in the treatment of Sjogren syndrome22 and
long-standing corneal epithelial defects,23 respectively,
without toxic effects, the reports on animal experimental
studies are contradictory. In all, 3% NAC has been shown
to reduce the healing time in dog and rabbit corneas12,13
whereas 10 and 20% concentrations had no effect in
dogs.12 Non-toxic effects of NAC have been reported in
rabbit cornea with topical application of 20% NAC 9,10
but frequent application of 0.1 M NAC for 2 h and 20%
NAC over 15 min were reported to have toxic effects.11
Further, 1% NAC was shown to reduce the cell survival
and gelatinase activity of primary rabbit corneal
epithelial cells.24 A recent study reported that 40 mM
NAC inhibited the corneal epithelial wound healing in a
pig eye organ culture system and constant presence of
NAC in the medium caused extensive HCE cell death
within 8 h.25 These reports and the finding of the present
study suggest that prolonged treatment of NAC has
adverse effects in the cornea. However, 20 mM or lower
doses may not be a problem clinically because NAC
eye drops are applied topically and NAC will become
diluted in the tear film immediately after application,
Figure 4 Effects of NAC on corneal epithelial cell migration.
(a) Representative phase contrast images of in vitro human
corneal epithelial wound closure for three different concentrations
(0, 1.0, and 20 mM) of NAC. Wound closure was photographed
immediately (0 h), 6 h, and 24 h after wounding. Arrows indicate
the edge of the wounds. (b) Histogram showing the migration
of epithelial cells after 6 and 24 h for different concentrations of
NAC. Each bar represents the mean±SEM of five samples.
Multiple pairwise comparisons showed significant differences
between 0 vs 10 mM (P¼ 0.0029), 0 vs 20 mM (Po0.0001), 0.1 vs
20 mM (Po0.0001), 1.0 vs 10 mM (P¼ 0.0008), 1.0 vs 20 mM
(Po0.0001), and 5 vs 20 mM (Po0.0001) NAC treatment groups.
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contrary to these cell cultures where dilution will not
occur.
In conclusion, these in vitro results show that NAC
inhibits the MMP-9 secretion in HCE cells, which is a
novel finding that may have potential application in the
management of conditions such as RCE and non-healing
corneal ulcers, where raised MMP-9 activity has been
implicated in the pathogenesis. Specifically, we suggest
NAC may have a potential therapeutic role for treatment
of RCEs.
Summary
What was known before
K NAC inhibits MMP-2.
What this study adds
K In vitro results show that NAC inhibits the MMP-9
secretion in HCE cells, which is a novel finding that
may have potential application in the management of
conditions such as recurrent corneal erosion and
non-healing corneal ulcers.
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